Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a large international population-based cohort study
Pancreatic cancer (PaC) remains extremely lethal worldwide even after resection. PaC resection rates are low, making prognostic studies in resected PaC difficult. This large international population-based study aimed at exploring factors associated with survival in patients with resected TNM stage I...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
25 March 2019
|
| In: |
BMC medicine
Year: 2019, Jahrgang: 17 |
| ISSN: | 1741-7015 |
| DOI: | 10.1186/s12916-019-1304-y |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1186/s12916-019-1304-y
|
| Verfasserangaben: | Lei Huang, Yesilda Balavarca, Lydia van der Geest, Valery Lemmens, Liesbet Van Eycken, Harlinde De Schutter, Tom B. Johannesen, Vesna Zadnik, Maja Primic-Žakelj, Margit Mägi, Robert Grützmann, Marc G. Besselink, Petra Schrotz-King, Hermann Brenner and Lina Jansen |
| Zusammenfassung: | Pancreatic cancer (PaC) remains extremely lethal worldwide even after resection. PaC resection rates are low, making prognostic studies in resected PaC difficult. This large international population-based study aimed at exploring factors associated with survival in patients with resected TNM stage I-II PaC receiving chemotherapy and at developing and internationally validating a survival-predicting model. |
|---|---|
| Beschreibung: | Gesehen am 08.04.2019 |
| Beschreibung: | Online Resource |
| ISSN: | 1741-7015 |
| DOI: | 10.1186/s12916-019-1304-y |